Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting

Ambu A/S12 enrolled

Overview

An Investigation to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung.

The purpose of this investigation it to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung. The hypothesis is that aScope 3 Large is able to manage the secretion and thereby facilitating the resolution of secretion in the lung.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Atelectasis Bronchoscopy

Interventions

Bronchoscopic procedureDEVICE

Single-use flexible bronchoscope aScope 3 Large

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients ≥18 years * Clinical indication and eligible for a BAL procedure, as judged by the investigator * Patients being admitted in the ICU at the investigational centre * Provision of signed IC by subject, or subject's legal representative e.g. next of kin Exclusion Criteria: * Patients where BAL treatment cannot be clinically justified, judged by the investigator * ETT \>7 mm and ≤8.5 mm in diameter * Participating in other interventional clinical investigations or have previously participated in this investigation

Locations (1)

University of Chicago Medicine

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Improvement in Oxygenation (PaO2/FiO2 Ratio) After a BAL Treatment

Resolution of atelectasis measured by improvement in oxygenation after a bronchoscopic procedure (bronchoalveolar lavage treatment). PaO2/FiO2 ratio will be compared between baseline and 4 hourst post the BAL procedure.

Time frame: 4 hours after procedure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.